MRD / Regn No. : 20250001006 Date : 23/06/2026
Patient Name : Subramanian MutHuraman Age & Gender : 71 Yrs. / Male
Contact No. : 8148761625 UHID :
Ht / Wt / BMI : 187 / 102 / 29.17 BP S / BP D : /
Allergies : NKA Referred By :
   
Problem List : TYPE 2 DM (17/Dec/2010) |
Subjective : TYPE 2 DM FOR 15 YEARS,NEPHROLITHIASIS,PATIENT NA,NO VOMITING
Objective : DIABETIC FOOT WITH FLAP WOUND
Analysis : TYPE 2 DM,OBESITY
Plan : INCREASE SEMAGLUTIDE TO 1.7 MG,DECREASE INSULIN TO 12 UNITS,SEE ME IN 2 MONTHS WITH TESTING  
Salient Investigations : FASTING PLASMA GLUCOSE (FPG): 110 mg/dL | POST PRANDIAL GLUCOSE (2HPP): 192 mg/dL
S# Generic (Trade) Name Route Dosage Usage Duration
1 TABLET DAPAGLIFLOZIN 10 MG
UDAPA
Medicine For DIABETES OBESITY HEART AND KIDNEY PROTECTION
PO 1-0-0 BEFORE FOOD
TILL NEXT VISIT
MAY CAUSE GENITOURINARY INFECTION. INFORM IF THERE IS DYSURIA OR GENITAL ITCHING
2 INJECTION DEGLUDEC / ASPART (INJ U100) 70/30
RYZODEG
Medicine For DIABETES
SQ 0-16-0 UNITS BEFORE FOOD
TILL NEXT VISIT
MAY CAUSE HYPOGLYCEMIA
3 INJECTION SEMAGLUTIDE 1.7 MG
WEGOVY 1.7 MG
Medicine For DIABETES OBESITY
SQ Q WEEKLY AS DIRECTED NO RELATION TO FOOD
TILL NEXT VISIT
MAY CAUSE NAUSEA AND VOMITING
       
Refill : 0 / Substitution:    
Education : CHECK GLUCOSE ALTERNATING MORNING AND EVENING IF MORNING GLUCOSE IS MORE THAN 12O INCREASE NIGHT DOSE BY 2 UNITS IF EVENING GLUCOSE IS MORE THAN 120 INCREASE MORNING DOSE BY 2 UNITS
Next Visit : 22/Aug/2026
Tests Suggested For Next Visit : FBS 2HPP SMBG HBA1C
   
   

Dr. Krishna G Seshadri
Sr. Consultant Endocrinology Diabetes and Metabolism
Tamil Nadu / 48748 HPRID: 71-0638-2075-7542

This is a Computer generated Prescription

Powered By: